Treatment of bacterial urinary tract infections: Presence and future

European Urology

Volumn 49, Issue 2, 2006, Pages 235-244

  Wagenlehner, Florian M E ^a   Naber, Kurt G ^a  

^a Urologische Klinik   (Germany)

Author keywords

Antibiotic resistance of uropathogens; Antibiotic treatment; New antiinfectives for treatment of UTI; Uncomplicated and complicated UTI; Urinary tract infections (UTI)

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME AXETIL; CEPHALOSPORIN; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GLYCOPEPTIDE; LEVOFLOXACIN; MECILLINAM; NITROFURAN; NORFLOXACIN; OXAZOLIDINONE DERIVATIVE; PIPERACILLIN; PIVMECILLINAM; PYRIMETHAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STROVAC; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNINDEXED DRUG; UREIDOPENICILLIN DERIVATIVE; URO VAXOM; VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHEMOTHERAPY; ESCHERICHIA COLI; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; URINARY TRACT INFECTIONS;

EID: 32044473765     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.017     Document Type: Review

References (50)

1. J.W. Warren, E. Abrutyn, J.R. Hebel, J.R. Johnson, A.J. Schaeffer, and W.E. Stamm Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 29 4 1999 745 758
2. B. Foxman Epidemiology of urinary tract infections: incidence, morbidity, and economic costs Am J Med 113 Suppl. 1A 2002 5S 13S
3. T. Mazzulli Resistance trends in urinary tract pathogens and impact on management J Urol 168 4 Pt 2 2002 1720 1722
4. A.C. Gales, R.N. Jones, and K.A. Gordon Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998) J Antimicrob Chemother 45 3 2000 295 303
5. H. Ruden, P. Gastmeier, F.D. Daschner, and M. Schumacher Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP) Infection 25 4 1997 199 202
6. D.G. Maki, and P.A. Tambyah Engineering out the risk for infection with urinary catheters Emerg Infect Dis 7 2 2001 342 347
7. J.P. Patton, D.B. Nash, and E. Abrutyn Urinary tract infection: economic considerations Med Clin North Am 75 2 1991 495 513
8. K.K. Lai, and S.A. Fontecchio Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients Am J Infect Control 30 4 2002 221 225
9. K.G. Naber Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents 17 4 2001 331 341
10. F. Wagenlehner, and K.G. Naber Antibiotics and resistance of uropathogens EAU Update Series 2 2004 125 135
11. E. Abraham, and E. Chain An encyme from bacteria able to destroy penicillin Nature 146 1940 837
12. H. Bauer, G.S. Bleßmann, D.B. Pitrow, and V.W. Rahlfs Prevention of recurrent urinary tract infections with immunoactive E. coli fractions Eur J Obstet Gyn 86 1999 33
13. H.W. Bauer, V.W. Rahlfs, P.A. Lauener, and G.S. Blessmann Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies Int J Antimicrob Agents 19 6 2002 451 456
14. H.W. Bauer, S. Alloussi, G. Egger, H.M. Blumlein, G. Cozma, and C.C. Schulman A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections Eur Urol 47 4 2005 542 548 discussion 548
15. X. Albert, I. Huertas, I.I. Pereiro, J. Sanfelix, V. Gosalbes, and C. Perrota Antibiotics for preventing recurrent urinary tract infection in non-pregnant women Cochrane Database Syst Rev 3 2004 CD001209
16. G. Riedasch, and K. Möhring Immunisierungstherapie rezidivierender Harnwegsinfekte der Frau Therapiewoche 6 1986 896 900
17. Reid G, Bruce RW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol in press.
18. G. Reid, A.W. Bruce, and M. Taylor Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections Microecol Ther 23 1995 32 45
19. G. Reid, D. Charbonneau, and J. Erb Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women FEMS Immunol Med Microbiol 35 2 2003 131 134
20. M. Fraga, P. Scavone, and P. Zunino Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model Antonie Van Leeuwenhoek 88 1 2005 25 34
21. V.A. Fischetti Bacteriophage lytic enzymes: novel anti-infectives Trends Microbiol 13 10 2005 491 496
22. Q. Cheng, D. Nelson, S. Zhu, and V.A. Fischetti Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme Antimicrob Agents Chemother 49 1 2005 111 117
23. P. Yoong, R. Schuch, D. Nelson, and V.A. Fischetti Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium J Bacteriol 186 14 2004 4808 4812
24. S. Langermann, R. Mollby, and J.E. Burlein Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli J Infect Dis 181 2 2000 774 778
25. R. Meiland, S.E. Geerlings, S. Langermann, E.C. Brouwer, F.E. Coenjaerts, and A.I. Hoepelman Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women J Urol 171 4 2004 1589 1593
26. D.T. Uehling, W.J. Hopkins, J.E. Elkahwaji, D.M. Schmidt, and G.E. Leverson Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections J Urol 170 3 2003 867 869
27. X. Li, and H.L. Mobley Vaccines for Proteus mirabilis in urinary tract infection Int J Antimicrob Agents 19 6 2002 461 465
28. X. Zhao, and K. Drlica Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies Clin Infect Dis 33 Suppl. 3 2001 S147 S156
29. K. Drlica Antibiotic resistance: can we beat the bugs? Drug Discov Today 6 14 2001 714 715
30. M. Sano, S. Takahashi, and M. Nishimura A clinical study on combination therapy of antimicrobial agents for complicated urinary tract infection-with special reference to combination with clarithromycin Nippon Hinyokika Gakkai Zasshi 88 6 1997 596 604
31. F. Vogel, K.G. Naber, H. Wacha, P. Shah, F. Sörgel, and F.H. Kayser Parenterale Antibiotika bei Erwachsenen Chemotherapie J 8 1999 2 49
32. D.R. Snydman, N.V. Jacobus, L.A. McDermott, J.R. Lonks, and J.M. Boyce Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens Antimicrob Agents Chemother 44 12 2000 3447 3450
33. V. Laganas, J. Alder, and J.A. Silverman In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis Antimicrob Agents Chemother 47 8 2003 2682 2684
34. P.C. Fuchs, A.L. Barry, and S.D. Brown In vitro bactericidal activity of daptomycin against staphylococci J Antimicrob Chemother 49 3 2002 467 470
35. A. Louie, P. Kaw, W. Liu, N. Jumbe, M.H. Miller, and G.L. Drusano Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection Antimicrob Agents Chemother 45 3 2001 845 851
36. J.R. Woodworth, E.H. Nyhart Jr., G.L. Brier, J.D. Wolny, and H.R. Black Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers Antimicrob Agents Chemother 36 2 1992 318 325
37. De Bruin MF, Tally FP. Efficacy and safety of daptomycin for the treatment of bacteremia and serious infections due to Gram-positive bacteria. in 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections, 2000 Vol. Abstract 594, 2000.
38. E. Rubinstein, and D. Vaughan Tigecycline: a novel glycylcycline Drugs 65 10 2005 1317 1336
39. Y. Kumamoto, T. Tsukamoto, and M. Matsukawa Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). I. Susceptibility distribution Jpn J Antibiot 57 3 2004 246 274
40. S. Heinzl Neue Antibiotika. Chemotherapie Journal 14 2005 54 57
41. R.N. Jones, H.S. Sader, and T.R. Fritsche Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms Diagn Microbiol Infect Dis 52 1 2005 71 74
42. D.C. Henry Jr., R.B. Bettis, and E. Riffer Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women Clin Ther 24 12 2002 2088 2104
43. F.M. Wagenlehner, M. Kinzig-Schippers, U. Tischmeyer, C. Wagenlehner, F. Sorgel, A. Dalhoff, and K.G. Naber Pharmacokinetics of ciprofloxacin XR (1000 mg) versus volunteers receiving a single oral dose Int J Antimicrob Agents Dec 9 2005 [Epub ahead of print]
44. D.A. Talan, K.G. Naber, J. Palou, and D. Elkharrat Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections Int J Antimicrob Agents 23 Suppl. 1 2004 S54 S66
45. E. Rubinstein History of quinolones and their side effects Chemotherapy 47 Suppl. 3 2001 3 8 discussion 44-48
46. A. Dalhoff, and F.J. Schmitz In vitro antibacterial activity and pharmacodynamics of new quinolones Eur J Clin Microbiol Infect Dis 22 4 2003 203 221
47. S. Eschenburg, M.A. Priestman, F.A. Abdul-Latif, C. Delachaume, F. Fassy, and E. Schonbrunn A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) J Biol Chem 280 14 2005 14070 14075
48. G.W. Kaatz Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance Expert Opin Emerg Drugs 7 2 2002 223 233
49. L. Heinisch, S. Wittmann, T. Stoiber, I. Scherlitz-Hofmann, D. Ankel-Fuchs, and U. Mollmann Synthesis and biological activity of tris- and tetrakiscatecholate siderophores based on poly-aza alkanoic acids or alkylbenzoic acids and their conjugates with beta-lactam antibiotics Arzneimittelforschung 53 3 2003 188 195
50. H.C. Neu The crisis in antibiotic resistance Science 257 5073 1992 1064 1073